Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Huge testicular lymphoma on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography-computed tomography.

Shen YY, Hsieh TC, Yen KY, Kao CH.

Am J Med Sci. 2013 Jun;345(6):490. doi: 10.1097/MAJ.0b013e318271c04d. No abstract available.

PMID:
23187303
2.

Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.

Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM.

Am J Hematol. 2014 Jul;89(7):726-31. doi: 10.1002/ajh.23730. Epub 2014 Apr 18.

3.

Recurrence of lymphoma presenting as asymmetrically increased testicular activity on FDG-PET/CT.

Kuo PH, Cooper DL, Cheng DW.

Semin Nucl Med. 2006 Jan;36(1):105-7. No abstract available.

PMID:
16356799
4.

Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?

Adams HJ, de Klerk JM, Fijnheer R, Heggelman BG, Dubois SV, Nievelstein RA, Kwee TC.

J Comput Assist Tomogr. 2015 Sep-Oct;39(5):810-5. doi: 10.1097/RCT.0000000000000270.

PMID:
26035406
5.

Positron emission tomography combined with computed tomography as an integral component in evaluation of primary cardiac lymphoma.

Lee JC, Platts DG, Huang YT, Slaughter RE.

Clin Cardiol. 2010 Jun;33(6):E106-8. doi: 10.1002/clc.20725.

6.

Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?

Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM.

Acta Radiol. 2015 Oct;56(10):1230-5. doi: 10.1177/0284185114554824. Epub 2014 Nov 11.

PMID:
25387723
7.

Positron emission tomography/computerized tomography in the evaluation of primary non-Hodgkin's lymphoma of prostate.

Pan B, Han JK, Wang SC, Xu A.

World J Gastroenterol. 2013 Oct 21;19(39):6699-702. doi: 10.3748/wjg.v19.i39.6699.

8.

RELIABILITY OF POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY IN EVALUATION OF TESTICULAR CARCINOMA PATIENTS.

Nikoletić K, Mihailović J, Matovina E, Žeravica R, Srbovan D.

Med Pregl. 2015 Mar-Apr;68(3-4):109-15.

PMID:
26214990
9.

Both Interim and End-of-Treatment 18F-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Scans Have Low Value in Diffuse Large B-Cell Lymphoma.

Adams HJ, Kwee TC.

J Clin Oncol. 2016 Mar 1;34(7):765-6. doi: 10.1200/JCO.2015.63.7728. Epub 2016 Jan 11. No abstract available.

PMID:
26755517
10.

Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma--a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography.

Wu X, Kellokumpu-Lehtinen PL, Pertovaara H, Korkola P, Soimakallio S, Eskola H, Dastidar P.

NMR Biomed. 2011 Dec;24(10):1181-90. doi: 10.1002/nbm.1689. Epub 2011 Mar 8.

PMID:
21387451
11.

Bilateral cutaneous diffuse large B-cell lymphoma on FDG PET/CT.

Kalender E, Yilmaz M, Erkilic S, Yilmaz M, Celen Z.

Clin Nucl Med. 2011 Oct;36(10):e153-5. doi: 10.1097/RLU.0b013e31821c9a7d. No abstract available.

PMID:
21892030
12.

Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy.

Cox MC, Ambrogi V, Lanni V, Cavalieri E, Pelliccia S, Scopinaro F, Monarca B, Marchetti P, Spiriti MA.

Leuk Lymphoma. 2012 Feb;53(2):263-9. doi: 10.3109/10428194.2011.614704. Epub 2011 Sep 23.

PMID:
21846184
13.

Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors.

Tsatalpas P, Beuthien-Baumann B, Kropp J, Manseck A, Tiepolt C, Hakenberg OW, Burchert W, Franke WG, Wirth MP.

Urol Int. 2002;68(3):157-63.

PMID:
11919460
14.

18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading.

Wöhrer S, Jaeger U, Kletter K, Becherer A, Hauswirth A, Turetschek K, Raderer M, Hoffmann M.

Ann Oncol. 2006 May;17(5):780-4. Epub 2006 Feb 23.

15.

Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.

Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, Birnbaum EH, Fleshman JW, Kodner IJ, Read TE.

Dis Colon Rectum. 2000 Jun;43(6):759-67; discussion 767-70.

PMID:
10859074
16.

The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.

Schrepfer T, Haerle SK, Strobel K, Schaefer N, Hälg RA, Huber GF.

Laryngoscope. 2010 May;120(5):937-44. doi: 10.1002/lary.20843.

PMID:
20422687
17.
18.

Re: 18F-FDG PET/CT Impact on Testicular Tumours Clinical Management.

Richie JP.

J Urol. 2015 Oct;194(4):991. doi: 10.1016/j.juro.2015.07.003. Epub 2015 Jul 7. No abstract available.

PMID:
26382779
19.

Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?

Adams HJ, Kwee TC, Nievelstein RA.

J Nucl Med. 2013 Nov;54(11):2017-8. doi: 10.2967/jnumed.113.126797. Epub 2013 Sep 5. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk